Physician Assistant, Medical · Las Vegas, NV
NPI
1497091870
Since 2012
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1701 Bearden Dr. Suite 200, Apex Medical Center
Las Vegas, NV, 89106
Phone (702) 310-9110
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,485 services
Medicare patients, 2024
163
Average age 66
Drug cost, 2024
$1.2M
8,230 prescriptions
Company payments, 2025
$1,950
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel A Lunini was code 99213 (office e&m - established), 710 times for 128 patients. In total Rachel A Lunini billed 1,485 services in 25 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 710 | 128 | $49.59 | $35K |
| 99214 Office E&M - Established | Office | 439 | 122 | $75.20 | $33K |
| 80307 Drug Tests | Office | 171 | 93 | $60.90 | $10K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 21 | 21 | $107.93 | $2,266 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 18 | 18 | $15.83 | $285 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 17 | $28.42 | $483 |
| 99205 Office E&M - New | Office | 12 | 12 | $132.49 | $1,590 |
| 90661 Vaccine Product | Office | 11 | 11 | $36.11 | $397 |
By year: 2022 $97K for 1,684 services; 2023 $93K for 1,627 services; 2024 $85K for 1,485 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 171 | 93 | $60.90 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Rachel A Lunini prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 730 prescriptions and refills. In total Rachel A Lunini wrote 8,230 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 730 | 730 | 103 | $71K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 618 | 618 | 93 | $20K |
| Oxycodone Hcl Generic | 312 | 312 | 50 | $4,723 |
| Gabapentin Generic | 311 | 505 | 73 | $5,184 |
| Morphine Sulfate Er Morphine Sulfate | 310 | 310 | 44 | $7,061 |
| Pregabalin Generic | 305 | 325 | 48 | $4,566 |
| Tizanidine Hcl Generic | 231 | 261 | 41 | $1,418 |
| Baclofen Generic | 212 | 246 | 36 | $2,010 |
| Atorvastatin Calcium Generic | 206 | 548 | 69 | $1,471 |
| Cyclobenzaprine Hcl Generic | 176 | 196 | 37 | $2,115 |
| Meloxicam Generic | 151 | 171 | 35 | $295 |
| Lisinopril Generic | 146 | 409 | 50 | $916 |
| Alprazolam Generic | 140 | 140 | 21 | $379 |
| Ozempic Semaglutide | 140 | 188 | 24 | $176K |
| Amlodipine Besylate Generic | 138 | 397 | 50 | $641 |
Brand drugs: 1,082 claims; generic drugs: 7,115 claims; opioid claims: 2,422.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel A Lunini $1,950 ($1,950 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $363.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $363 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $292 |
| Forte Bio-Pharma LLC | 8 | $258 |
| ANI Pharmaceuticals, Inc. ANIP | 7 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $151 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $95.26 |
| Protega Pharmaceutials Inc | 5 | $93.47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $82.61 |
| Novo Nordisk Inc NVO | 4 | $65.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.